{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:42:12Z","timestamp":1785213732505,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["29224"],"award-info":[{"award-number":["29224"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00210-022-02331-2","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:18:15Z","timestamp":1669303095000},"page":"1547-1561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function"],"prefix":"10.1007","volume":"396","author":[{"given":"Andleeb","family":"Shahzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Eyileten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Postula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra Guzel","family":"Tanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Karatas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Boray","family":"Basci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oner","family":"Suzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliha","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"2331_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.biopha.2017.05.049","volume":"92","author":"AM Abdelrady","year":"2017","unstructured":"Abdelrady AM, Zaitone SA, Farag NE, Fawzy MS, Moustafa YM (2017) Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with\/without acute myocardial infarction: impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels. Biomed Pharmacother 92:196\u2013206","journal-title":"Biomed Pharmacother"},{"key":"2331_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1113\/EP085380","volume":"101","author":"D Aksentijevi\u0107","year":"2016","unstructured":"Aksentijevi\u0107 D, Lewis HR, Shattock MJ (2016) Is rate-pressure product of any use in the isolated rat heart? Assessing cardiac \u2018effort\u2019 and oxygen consumption in the Langendorff-perfused heart. Exp Physiol 101:282\u2013294","journal-title":"Exp Physiol"},{"key":"2331_CR3","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1056\/NEJMe020049","volume":"346","author":"EM Antman","year":"2002","unstructured":"Antman EM (2002) Decision making with cardiac troponin tests. N Engl J Med 346:2079\u20132082","journal-title":"N Engl J Med"},{"key":"2331_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1517\/17425255.2014.872240","volume":"10","author":"N Aspromonte","year":"2014","unstructured":"Aspromonte N, Monitillo F, Puzzovivo A, Valle R, Caldarola P, Iacoviello M (2014) Modulation of cardiac cytochrome P450 in patients with heart failure. Expert Opin Drug Metab Toxicol 10:327\u2013339","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2331_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/0277-5379(89)90135-1","volume":"25","author":"SS Bielack","year":"1989","unstructured":"Bielack SS, Erttmann R, Winkler K, Landbeck G (1989) Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy. Eur J Cancer Clin Oncol 25:873\u2013882","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2331_CR6","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1006\/jmcc.1997.0494","volume":"29","author":"RJ Boucek Jr","year":"1997","unstructured":"Boucek RJ Jr, Dodd DA, Atkinson JB, Oquist N, Olson RD (1997) Contractile failure in chronic doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol 29:2631\u20132640","journal-title":"J Mol Cell Cardiol"},{"key":"2331_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/AC.67.1.2146570","volume":"67","author":"E Bozcali","year":"2012","unstructured":"Bozcali E, Dedeoglu DB, Karpuz V, Suzer O, Karpuz H (2012) Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia\/reperfusion injury as well as doxorubicin cardiotoxicity. Acta Cardiol 67:87\u201396","journal-title":"Acta Cardiol"},{"key":"2331_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/1097-0142(197310)32:4<771::AID-CNCR2820320407>3.0.CO;2-A","volume":"32","author":"LM Buja","year":"1973","unstructured":"Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES (1973) Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32:771\u2013788","journal-title":"Cancer"},{"key":"2331_CR9","doi-asserted-by":"publisher","first-page":"R837","DOI":"10.1152\/ajpregu.00376.2006","volume":"292","author":"T Bupha-Intr","year":"2007","unstructured":"Bupha-Intr T, Wattanapermpool J, Pe\u00f1a JR, Wolska BM, Solaro RJ (2007) Myofilament response to Ca2+ and Na+\/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis. Am J Physiol Regul Integr Comp Physiol 292:R837-843","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2331_CR10","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1210\/en.2003-0058","volume":"144","author":"F Callies","year":"2003","unstructured":"Callies F, Str\u00f6mer H, Schwinger RH, B\u00f6lck B, Hu K, Frantz S, Leupold A, Beer S, Allolio B, Bonz AW (2003) Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology 144:4478\u20134483","journal-title":"Endocrinology"},{"key":"2331_CR11","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.7150\/thno.47407","volume":"10","author":"N Chakouri","year":"2020","unstructured":"Chakouri N, Farah C, Matecki S, Amedro P, Vincenti M, Saumet L, Vergely L, Sirvent N, Lacampagne A, Cazorla O (2020) Screening for in-vivo regional contractile defaults to predict the delayed doxorubicin cardiotoxicity in juvenile rat. Theranostics 10:8130\u20138142","journal-title":"Theranostics"},{"key":"2331_CR12","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.1999.17.8.2341","volume":"17","author":"S Chan","year":"1999","unstructured":"Chan S, Friedrichs K, Noel D, Pint\u00e9r T, Van Belle S, Vorobiof D, Duarte R, Gil Gil M, Bodrogi I, Murray E, Yelle L, von Minckwitz G, Korec S, Simmonds P, Buzzi F, Gonz\u00e1lez Mancha R, Richardson G, Walpole E, Ronzoni M, Murawsky M, Alakl M, Riva A, Crown J (1999) Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17:2341\u20132354","journal-title":"J Clin Oncol"},{"key":"2331_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee K, Zhang J, Honbo N, Karliner JS (2010) Doxorubicin cardiomyopathy. Cardiology 115:155\u2013162","journal-title":"Cardiology"},{"key":"2331_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/iub.241","volume":"61","author":"KR Chaudhary","year":"2009","unstructured":"Chaudhary KR, Batchu SN, Seubert JM (2009) Cytochrome P450 enzymes and the heart. IUBMB Life 61:954\u2013960","journal-title":"IUBMB Life"},{"key":"2331_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0003-9861(03)00174-7","volume":"414","author":"D Choudhary","year":"2003","unstructured":"Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91\u2013100","journal-title":"Arch Biochem Biophys"},{"key":"2331_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.11882","volume":"100","author":"J Crawford","year":"2004","unstructured":"Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100:228\u2013237","journal-title":"Cancer"},{"key":"2331_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/annonc\/mdh107","volume":"15","author":"S Cresta","year":"2004","unstructured":"Cresta S, Grasselli G, Mansutti M, Martoni A, Lelli G, Capri G, Buzzi F, Cuna GR, Jirillo A, Terzoli E, Frevola L, Tarenzi E, Sguotti C, Azli N, Murawsky M, Gianni L (2004) A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer. Ann Oncol 15:433\u2013439","journal-title":"Ann Oncol"},{"key":"2331_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2165\/00003088-200241060-00004","volume":"41","author":"R Danesi","year":"2002","unstructured":"Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M (2002) Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet 41:431\u2013444","journal-title":"Clin Pharmacokinet"},{"key":"2331_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejca.2007.12.010","volume":"44","author":"F de Nigris","year":"2008","unstructured":"de Nigris F, Rienzo M, Schiano C, Fiorito C, Casamassimi A, Napoli C (2008) Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. Eur J Cancer 44:334\u2013340","journal-title":"Eur J Cancer"},{"key":"2331_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pharmthera.2005.05.011","volume":"112","author":"RH Elbekai","year":"2006","unstructured":"Elbekai RH, El-Kadi AO (2006) Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther 112:564\u2013587","journal-title":"Pharmacol Ther"},{"key":"2331_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4236\/pp.2012.32028","volume":"3","author":"NB Elias Adikwu","year":"2012","unstructured":"Elias Adikwu NB (2012) Ciprofloxacin cardiotoxicity and hepatotoxicity in humans and animals. Pharmacology and Pharmacy 3:207\u20132013","journal-title":"Pharmacology and Pharmacy"},{"key":"2331_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.587149","volume":"8","author":"MJ Engwall","year":"2021","unstructured":"Engwall MJ, Everds N, Turk JR, Vargas HM (2021) The effects of repeat-dose doxorubicin on cardiovascular functional endpoints and biomarkers in the telemetry-equipped cynomolgus monkey. Front Cardiovasc Med 8:587149","journal-title":"Front Cardiovasc Med"},{"key":"2331_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5505\/ejm.2016.19483","volume":"21","author":"Z Erdo\u011fmu\u015f \u00d6zgen","year":"2016","unstructured":"Erdo\u011fmu\u015f \u00d6zgen Z, Erdin\u00e7 M, Akko\u00e7 H, Kelle \u0130 (2016) Protective effects of melatonin on doxorubicin induced cardiotoxicity in isolated rat heart. Eastern J Med 21:119\u2013124","journal-title":"Eastern J Med"},{"key":"2331_CR24","doi-asserted-by":"crossref","unstructured":"Eyileten C, Fitas A, Jakubik D, Czajka P, Mr\u00f3z A, Czajkowska A, Witek K, Bakalarski W, De Rosa S, Postu\u0142a M, Ma\u0142ek \u0141A (2021) Alterations in circulating microRNAs and the relation of microRNAs to maximal oxygen consumption and intima-media thickness in ultra-marathon runners. Int J Environ Res Public Health 18","DOI":"10.3390\/ijerph18147234"},{"key":"2331_CR25","doi-asserted-by":"publisher","unstructured":"Eyileten C, Wicik Z, Fitas A, Marszalek M, Simon JE, De Rosa S, Wiecha S, Palatini J, Postula M, Malek LA (2022) Altered circulating MicroRNA profiles after endurance training: a cohort study of ultramarathon runners. Front. Physiol 12:792931.\u00a0https:\/\/doi.org\/10.3389\/fphys.2021.792931","DOI":"10.3389\/fphys.2021.792931"},{"key":"2331_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/01.CIR.0000160359.49478.C2","volume":"111","author":"PW Fisher","year":"2005","unstructured":"Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC (2005) Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 111:1601\u20131610","journal-title":"Circulation"},{"key":"2331_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.taap.2012.12.003","volume":"268","author":"M Gharanei","year":"2013","unstructured":"Gharanei M, Hussain A, Janneh O, Maddock HL (2013) Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore. Toxicol Appl Pharmacol 268:149\u2013156","journal-title":"Toxicol Appl Pharmacol"},{"key":"2331_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.clpt.2004.08.018","volume":"76","author":"MT Granfors","year":"2004","unstructured":"Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ (2004) Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism. Clin Pharmacol Ther 76:598\u2013606","journal-title":"Clin Pharmacol Ther"},{"key":"2331_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cardiores.2005.06.007","volume":"68","author":"GJ Gross","year":"2005","unstructured":"Gross GJ, Falck JR, Gross ER, Isbell M, Moore J, Nithipatikom K (2005) Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia\/reperfusion injury revisited. Cardiovasc Res 68:18\u201325","journal-title":"Cardiovasc Res"},{"key":"2331_CR30","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1080\/00498250701534893","volume":"37","author":"NJ Hewitt","year":"2007","unstructured":"Hewitt NJ, Lecluyse EL, Ferguson SS (2007) Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica 37:1196\u20131224","journal-title":"Xenobiotica"},{"key":"2331_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3109\/15376516.2013.773391","volume":"23","author":"LD Hole","year":"2013","unstructured":"Hole LD, Larsen TH, Fossan KO, Lim\u00e9 F, Schj\u00f8tt J (2013) A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat. Toxicol Mech Methods 23:412\u2013418","journal-title":"Toxicol Mech Methods"},{"key":"2331_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2050-6511-15-28","volume":"15","author":"LD Hole","year":"2014","unstructured":"Hole LD, Larsen TH, Fossan KO, Lim\u00e9 F, Schj\u00f8tt J (2014) Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat. BMC Pharmacol Toxicol 15:28","journal-title":"BMC Pharmacol Toxicol"},{"key":"2331_CR33","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1210\/mend-3-9-1399","volume":"3","author":"K Ikeya","year":"1989","unstructured":"Ikeya K, Jaiswal AK, Owens RA, Jones JE, Nebert DW, Kimura S (1989) Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol Endocrinol 3:1399\u20131408","journal-title":"Mol Endocrinol"},{"key":"2331_CR34","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.87.11.4275","volume":"87","author":"H Ito","year":"1990","unstructured":"Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM (1990) Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A 87:4275\u20134279","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2331_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bcp.2017.09.012","volume":"146","author":"A Karkhanis","year":"2017","unstructured":"Karkhanis A, Tram NDT, Chan ECY (2017) Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids. Biochem Pharmacol 146:188\u2013198","journal-title":"Biochem Pharmacol"},{"key":"2331_CR36","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/bcp.12425","volume":"78","author":"S Kasichayanula","year":"2014","unstructured":"Kasichayanula S, Boulton DW, Luo WL, Rodrigues AD, Yang Z, Goodenough A, Lee M, Jemal M, LaCreta F (2014) Validation of 4\u03b2-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects. Br J Clin Pharmacol 78:1122\u20131134","journal-title":"Br J Clin Pharmacol"},{"key":"2331_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/abbi.1993.1587","volume":"307","author":"S Kirita","year":"1993","unstructured":"Kirita S, Matsubara T (1993) cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch Biochem Biophys 307:253\u2013258","journal-title":"Arch Biochem Biophys"},{"key":"2331_CR38","doi-asserted-by":"publisher","unstructured":"Klomp F, Wenzel C, Drozdzik M, Oswald S (2020) Drug-Drug interactions involving intestinal and hepatic CYP1A enzymes. Pharmaceutics 12(12):1201. https:\/\/doi.org\/10.3390\/pharmaceutics12121201","DOI":"10.3390\/pharmaceutics12121201"},{"key":"2331_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2146\/ajhp070081","volume":"65","author":"JP Knorr","year":"2008","unstructured":"Knorr JP, Moshfeghi M, Sokoloski MC (2008) Ciprofloxacin-induced Q-T interval prolongation. Am J Health Syst Pharm 65:547\u2013551","journal-title":"Am J Health Syst Pharm"},{"key":"2331_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00041433-200206000-00007","volume":"13","author":"DL Kroetz","year":"2002","unstructured":"Kroetz DL, Zeldin DC (2002) Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 13:273\u2013283","journal-title":"Curr Opin Lipidol"},{"key":"2331_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","volume":"32","author":"EA Lefrak","year":"1973","unstructured":"Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302\u2013314","journal-title":"Cancer"},{"key":"2331_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4049\/jimmunol.178.2.641","volume":"178","author":"SP Levick","year":"2007","unstructured":"Levick SP, Loch DC, Taylor SM, Janicki JS (2007) Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 178:641\u2013646","journal-title":"J Immunol"},{"key":"2331_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"2331_CR44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","volume":"98","author":"JD Marsh","year":"1998","unstructured":"Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256\u2013261","journal-title":"Circulation"},{"key":"2331_CR45","first-page":"1134","volume":"24","author":"RA McLellan","year":"1996","unstructured":"McLellan RA, Drobitch RK, Monshouwer M, Renton KW (1996) Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human. Drug Metab Dispos 24:1134\u20131138","journal-title":"Drug Metab Dispos"},{"key":"2331_CR46","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1124\/dmd.114.058040","volume":"42","author":"S Michaels","year":"2014","unstructured":"Michaels S, Wang MZ (2014) The revised human liver cytochrome P450 \u201cpie\u201d: absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics. Drug Metab Dispos 42:1241\u20131251","journal-title":"Drug Metab Dispos"},{"key":"2331_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0014-5793(99)00612-2","volume":"452","author":"Y Minamiyama","year":"1999","unstructured":"Minamiyama Y, Takemura S, Akiyama T, Imaoka S, Inoue M, Funae Y, Okada S (1999) Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Lett 452:165\u2013169","journal-title":"FEBS Lett"},{"key":"2331_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-4939-8597-5_17","volume":"1816","author":"T Nakahara","year":"2018","unstructured":"Nakahara T, Tanimoto T, Petrov AD, Ishikawa K, Strauss HW, Narula J (2018) Rat model of cardiotoxic drug-induced cardiomyopathy. Methods Mol Biol 1816:221\u2013232","journal-title":"Methods Mol Biol"},{"key":"2331_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1258\/002367706776319042","volume":"40","author":"PJ O'Brien","year":"2006","unstructured":"O\u2019Brien PJ, Smith DE, Knechtel TJ, Marchak MA, Pruimboom-Brees I, Brees DJ, Spratt DP, Archer FJ, Butler P, Potter AN, Provost JP, Richard J, Snyder PA, Reagan WJ (2006) Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim 40:153\u2013171","journal-title":"Lab Anim"},{"key":"2331_CR50","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1124\/dmd.105.008672","volume":"34","author":"MF Paine","year":"2006","unstructured":"Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC (2006) The human intestinal cytochrome P450 \u201cpie.\u201d Drug Metab Dispos 34:880\u2013886","journal-title":"Drug Metab Dispos"},{"key":"2331_CR51","doi-asserted-by":"publisher","unstructured":"Podyacheva EY, Kushnareva EA, Karpov AA, Toropova YG (2021) Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. a modern view from the perspective of the pathophysiologist and the clinician. Front Pharmacol 12:670479.\u00a0https:\/\/doi.org\/10.3389\/fphar.2021.670479","DOI":"10.3389\/fphar.2021.670479"},{"key":"2331_CR52","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.hrthm.2004.06.020","volume":"1","author":"M Prabhakar","year":"2004","unstructured":"Prabhakar M, Krahn AD (2004) Ciprofloxacin-induced acquired long QT syndrome. Heart Rhythm 1:624\u2013626","journal-title":"Heart Rhythm"},{"key":"2331_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10565-006-0142-9","volume":"23","author":"J Robert","year":"2007","unstructured":"Robert J (2007) Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls. Cell Biol Toxicol 23:27\u201337","journal-title":"Cell Biol Toxicol"},{"key":"2331_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00021.2001","volume":"82","author":"RJ Roman","year":"2002","unstructured":"Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131\u2013185","journal-title":"Physiol Rev"},{"key":"2331_CR55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/01480540902882176","volume":"32","author":"A Sara\u00e7o\u011flu","year":"2009","unstructured":"Sara\u00e7o\u011flu A, Temel HE, Ergun B, Colak O (2009) Oxidative stress-mediated myocardiotoxicity of ciprofloxacin and ofloxacin in juvenile rats. Drug Chem Toxicol 32:238\u2013242","journal-title":"Drug Chem Toxicol"},{"key":"2331_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0736-4679(02)00463-8","volume":"23","author":"J Sarko","year":"2002","unstructured":"Sarko J, Pollack CV Jr (2002) Cardiac troponins. J Emerg Med 23:57\u201365","journal-title":"J Emerg Med"},{"key":"2331_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/01.RES.61.1.12","volume":"61","author":"J Scheuer","year":"1987","unstructured":"Scheuer J, Malhotra A, Schaible TF, Capasso J (1987) Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61:12\u201319","journal-title":"Circ Res"},{"key":"2331_CR58","doi-asserted-by":"crossref","unstructured":"Shahzadi A, Sonmez I, Allahverdiyev O, Onal B, Kandaz C, Ozyazgan SO, Akkan AG, Yazici Z (2014) Cardiac Troponin-I (cTnI) a biomarker of cardiac injuries induced by doxorubicin alone and in combination with ciprofloxacin, following acute and chronic dose protocol in Sprague Dawley Rats. Int J Pharmacol 10:258\u2013266","DOI":"10.3923\/ijp.2014.258.266"},{"key":"2331_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330\u2013352","journal-title":"Prog Cardiovasc Dis"},{"key":"2331_CR60","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/sj.bjp.0703465","volume":"130","author":"T Thum","year":"2000","unstructured":"Thum T, Borlak J (2000a) Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat. Br J Pharmacol 130:1745\u20131752","journal-title":"Br J Pharmacol"},{"key":"2331_CR61","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(00)99016-0","volume":"355","author":"T Thum","year":"2000","unstructured":"Thum T, Borlak J (2000b) Gene expression in distinct regions of the heart. Lancet 355:979\u2013983","journal-title":"Lancet"},{"key":"2331_CR62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/cvr\/cvr007","volume":"90","author":"M Volkova","year":"2011","unstructured":"Volkova M, Palmeri M, Russell KS, Russell RR (2011) Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart. Cardiovasc Res 90:305\u2013314","journal-title":"Cardiovasc Res"},{"key":"2331_CR63","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710\u2013717","journal-title":"Ann Intern Med"},{"key":"2331_CR64","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1016\/S0021-9258(19)84558-1","volume":"261","author":"PB Watkins","year":"1986","unstructured":"Watkins PB, Wrighton SA, Schuetz EG, Maurel P, Guzelian PS (1986) Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture. J Biol Chem 261:6264\u20136271","journal-title":"J Biol Chem"},{"key":"2331_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1050-1738(03)00027-6","volume":"13","author":"Y Wen","year":"2003","unstructured":"Wen Y, Gu J, Peng X, Zhang G, Nadler J (2003) Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. Trends Cardiovasc Med 13:129\u2013136","journal-title":"Trends Cardiovasc Med"},{"key":"2331_CR66","doi-asserted-by":"publisher","first-page":"12551","DOI":"10.1074\/jbc.272.19.12551","volume":"272","author":"S Wu","year":"1997","unstructured":"Wu S, Chen W, Murphy E, Gabel S, Tomer KB, Foley J, Steenbergen C, Falck JR, Moomaw CR, Zeldin DC (1997) Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes*. J Biol Chem 272:12551\u201312559","journal-title":"J Biol Chem"},{"key":"2331_CR76","doi-asserted-by":"crossref","unstructured":"Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A (2003) Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. Pharmacogenomics J 3:53\u201361","DOI":"10.1038\/sj.tpj.6500157"},{"key":"2331_CR67","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.addr.2011.03.006","volume":"63","author":"X Xu","year":"2011","unstructured":"Xu X, Zhang XA, Wang DW (2011) The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev 63:597\u2013609","journal-title":"Adv Drug Deliv Rev"},{"key":"2331_CR68","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.bcp.2007.06.031","volume":"74","author":"YC Yeh","year":"2007","unstructured":"Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC, Liu TJ (2007) Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol 74:969\u2013980","journal-title":"Biochem Pharmacol"},{"key":"2331_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103\u2013141","journal-title":"Pharmacol Ther"},{"key":"2331_CR70","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/0192623313482778","volume":"42","author":"J Zhang","year":"2014","unstructured":"Zhang J, Knapton A, Lipshultz SE, Cochran TR, Hiraragi H, Herman EH (2014) Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats. Toxicol Pathol 42:361\u2013375","journal-title":"Toxicol Pathol"},{"key":"2331_CR71","doi-asserted-by":"publisher","first-page":"H37","DOI":"10.1152\/ajpheart.00983.2008","volume":"297","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, El-Sikhry H, Chaudhary KR, Batchu SN, Shayeganpour A, Jukar TO, Bradbury JA, Graves JP, DeGraff LM, Myers P, Rouse DC, Foley J, Nyska A, Zeldin DC, Seubert JM (2009) Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 297:H37-46","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2331_CR72","doi-asserted-by":"publisher","first-page":"44735","DOI":"10.1038\/srep44735","volume":"7","author":"L Zhao","year":"2017","unstructured":"Zhao L, Zhang B (2017) Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep 7:44735","journal-title":"Sci Rep"},{"key":"2331_CR73","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1124\/dmd.108.023077","volume":"36","author":"BN Zordoky","year":"2008","unstructured":"Zordoky BN, Aboutabl ME, El-Kadi AO (2008) Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metab Dispos 36:2277\u20132286","journal-title":"Drug Metab Dispos"},{"key":"2331_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","volume":"242","author":"BN Zordoky","year":"2010","unstructured":"Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO (2010) Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol Appl Pharmacol 242:38\u201346","journal-title":"Toxicol Appl Pharmacol"},{"key":"2331_CR75","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.vph.2008.07.004","volume":"49","author":"BN Zordoky","year":"2008","unstructured":"Zordoky BN, El-Kadi AO (2008) Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. Vascul Pharmacol 49:166\u2013172","journal-title":"Vascul Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02331-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02331-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:09:50Z","timestamp":1686092990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02331-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02331-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate."}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}